Thermo Fisher Scientific Inc on Wednesday raised its full-year revenue outlook, but cut its COVID-19 test sales forecast by $900 million, citing slowing demand for the rest of the year as ...

Thermo Fisher, the biggest maker of scientific instruments, now expects COVID-19 testing revenue of $4.9 billion for 2021, down from $5.8 billion it expected earlier.